首页|肠道菌群与骨质疏松症相关分子机制的研究进展

肠道菌群与骨质疏松症相关分子机制的研究进展

扫码查看
肠道菌群是指生活在人体消化道内并与人体共生的微生物群落,目前被认为是一个对胃肠道、免疫和内分泌系统有直接影响的"大器官",能够直接或间接地参与调节人体的各种生理和病理过程。近年来,越来越多的临床和实验证据表明,肠道菌群与骨质疏松症之间存在密切联系,益生菌已被证明可通过胃肠道对维持骨骼健康有积极影响。本文总结了近年来国内外针对此观点的各项研究,对肠道菌群调节骨质疏松症的分子机制以及利用肠道菌群改善骨健康的临床实践作一综述。目前公认的主要机制包括内分泌调节、免疫调节(Th17/Treg细胞平衡)和基因调节(miRNAs)。同时发现将补充益生菌和益生元作为治疗骨质疏松症的一种方式有望成为今后科研和临床研究的新思路。
The relationship between gut microbiota and osteoporosis and its prevention and treatment strategies
Gut microbiota refers to the microbial community that lives in the human digestive tract and coexists with the human body.At present,it is considered as a"large organ"that has a direct impact on the gastrointestinal tract,immune and endocrine systems.Gut microbiota directly or indirectly participates in the regulation of various physiological and patholo-gical processes of the human body.In recent years,a growing number of clinical and experimental evidences have shown that there is a close relationship between gut microbiota and osteoporosis,and probiotics have been proved to have a posit-ive impact on maintaining bone health through the gastrointestinal tract.In this paper,we summarized various domestic and foreign studies on this topic in recent years,the molecular mechanism of the regulatory effect of gut microbiota on osteo-porosis and the clinical practice of using gut microbiota to improve bone health.We believe that the main mechanisms re-cognized at present are:endocrine regulation,immune regulation(Th17/Treg cell balance),and gene regulation(miRNAs).At the same time,we also find that probiotics and prebiotics as a way to treat osteoporosis is expected to become a new idea for future scientific and clinical research.

Gut microbiotaOsteoporosisEndocrineImmune regulationmiRNAProbiotics

王子豪、王宇、杨鑫、张瑜晗、袁涛

展开 >

云南省肿瘤医院(昆明医科大学第三附属医院)骨科,云南昆明 650118

南昌大学生命科学学院

肠道菌群 骨质疏松症 内分泌 免疫调节 miRNA 益生菌

云南省科技厅科技计划项目云南省卫生内设研究机构项目

202201AT0700122017NS197

2024

中国微生态学杂志
中华预防医学会 大连医科大学

中国微生态学杂志

CSTPCD北大核心
影响因子:1.115
ISSN:1005-376X
年,卷(期):2024.36(4)
  • 37